Literature DB >> 16331470

Nodular lymphoid lesion of the liver with simultaneous focal nodular hyperplasia and hemangioma: discrimination from primary hepatic MALT-type non-Hodgkin's lymphoma.

Klaus Willenbrock1, Susanne Kriener, Sabine Oeschger, Martin-Leo Hansmann.   

Abstract

Nodular lymphoid lesion (NLL) of the liver is a rare but unique entity and has also been termed reactive lymphoid hyperplasia of the liver. We describe the histological, immunohistochemical and molecular biologic findings of a case with NLL and two other tumors of the liver. The nodular lymphoid mass found in the liver was composed of heterogeneous small lymphocytes forming reactive follicles. Plasma cells, few immunoblasts, centroblasts, few macrophages, epithelioid cells, and giant cells were seen. The lymphoid infiltrate displaced the adjacent hepatic parenchyma. By immunohistochemistry and molecular studies, the lymphocytes were found to be polyclonal. The diagnosis of NLL was made. In addition to NLL, focal nodular hyperplasia and hemangioma were detected. The discrimination of NLL from primary hepatic malignant non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue-type may pose diagnostic difficulties and may require the use of immunohistochemical and molecular techniques. The simultaneous occurrence of NLL with focal nodular hyperplasia and hemangioma in the liver has not been described before.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331470     DOI: 10.1007/s00428-005-0126-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  [Lymphoma-simulating presentation of focal nodular hyperplasia (FNH) of the liver].

Authors:  D Schmitz; H H Köhler; C P Heussel; H F Löhr; P R Galle
Journal:  Z Gastroenterol       Date:  2001-03       Impact factor: 2.000

Review 2.  A case of pseudolymphoma of the liver with chronic hepatitis C.

Authors:  S R Kim; Y Hayashi; K B Kang; C G Soe; J H Kim; M K Yang; H Itoh
Journal:  J Hepatol       Date:  1997-01       Impact factor: 25.083

3.  Reactive lymphoid hyperplasia of the liver.

Authors:  H Isobe; S Sakamoto; H Sakai; A Masumoto; T Sonoda; E Adachi; H Nawata
Journal:  J Clin Gastroenterol       Date:  1993-04       Impact factor: 3.062

4.  Primary hepatic B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  C M Kirk; D Lewin; J Lazarchick
Journal:  Arch Pathol Lab Med       Date:  1999-08       Impact factor: 5.534

5.  Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases.

Authors:  M Maes; C Depardieu; J L Dargent; M Hermans; J L Verhaeghe; J Delabie; S Pittaluga; P Troufléau; A Verhest; C De Wolf-Peeters
Journal:  J Hepatol       Date:  1997-11       Impact factor: 25.083

6.  Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Emanuele Zucca; Annarita Conconi; Ennio Pedrinis; Sergio Cortelazzo; Teresio Motta; Mary K Gospodarowicz; Bruce J Patterson; Andrés J M Ferreri; Maurilio Ponzoni; Liliana Devizzi; Roberto Giardini; Graziella Pinotti; Carlo Capella; Pier Luigi Zinzani; Stefano Pileri; Armando López-Guillermo; Elias Campo; Achille Ambrosetti; Luca Baldini; Franco Cavalli
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

7.  Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients.

Authors:  Jean-Pierre Bronowicki; Catherine Bineau; Pierre Feugier; Olivier Hermine; Nicole Brousse; Frédéric Oberti; Marie-Christine Rousselet; Sébastien Dharancy; Philippe Gaulard; Jean-François Flejou; Dominique Cazals-Hatem; Eric Labouyrie
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  A case of pseudolymphoma of the liver.

Authors:  K Katayanagi; T Terada; Y Nakanuma; T Ueno
Journal:  Pathol Int       Date:  1994-09       Impact factor: 2.534

Review 9.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

10.  Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B.

Authors:  T Ohtsu; Y Sasaki; H Tanizaki; N Kawano; M Ryu; M Satake; T Hasebe; K Mukai; M Fujikura; M Tamai
Journal:  Intern Med       Date:  1994-01       Impact factor: 1.271

View more
  12 in total

1.  Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge.

Authors:  Yong Kyong Kwon; Reena C Jha; Kambiz Etesami; Thomas M Fishbein; Metin Ozdemirli; Chirag S Desai
Journal:  World J Hepatol       Date:  2015-11-18

2.  Hepatic nodular lymphoid lesion with increased IgG4-positive plasma cells associated with primary biliary cirrhosis: a report of two cases.

Authors:  Jessica Calvo; Nicolas Carbonell; Olivier Scatton; Christophe Marzac; Nathalie Ganne-Carrie; Dominique Wendum
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

3.  Hepatic reactive lymphoid hyperplasia in a patient with primary biliary cirrhosis.

Authors:  Mitsuaki Ishida; Tamio Nakahara; Yousuke Mochizuki; Tomoyuki Tsujikawa; Akira Andoh; Yasuharu Saito; Hiroshi Yamamoto; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Hepatol       Date:  2010-10-27

Review 4.  Pseudolymphoma of the liver associated with primary biliary cirrhosis: a case report and review of literature.

Authors:  Toshihide Okada; Hiroshi Mibayashi; Kenkei Hasatani; Yoshiaki Hayashi; Shigetsugu Tsuji; Yoshibumi Kaneko; Masashi Yoshimitsu; Takashi Tani; Yoh Zen; Masakazu Yamagishi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

5.  Etiological factors in primary hepatic B-cell lymphoma.

Authors:  Kanta Kikuma; Jiro Watanabe; Yumi Oshiro; Tatsuo Shimogama; Yumi Honda; Seiichi Okamura; Koichi Higaki; Naokuni Uike; Tetsuro Soda; Seiya Momosaki; Tadaaki Yokota; Satoshi Toyoshima; Morishige Takeshita
Journal:  Virchows Arch       Date:  2012-03-07       Impact factor: 4.064

6.  Reactive lymphoid hyperplasia of the liver: a clinicopathological study of 7 cases.

Authors:  Lei Yuan; Youlei Zhang; Yi Wang; Wenming Cong; Mengchao Wu
Journal:  HPB Surg       Date:  2012-07-30

7.  Complete response to comprehensive treatment of a primary hepatic diffuse large B cell lymphoma: A case report.

Authors:  Kai Jing Zhang; Sai Chen; Jian Lin Chen; Li Hua Dong
Journal:  Oncol Lett       Date:  2015-01-29       Impact factor: 2.967

8.  A case of contiguous primary hepatic marginal zone B-cell lymphoma and hemangioma ultimately diagnosed using contrast-enhanced ultrasonography.

Authors:  Kazue Shiozawa; Manabu Watanabe; Takashi Ikehara; Yasushi Matsukiyo; Yoshinori Kikuchi; Hironori Kaneko; Yoichiro Okubo; Kazutoshi Shibuya; Yoshinori Igarashi; Yasukiyo Sumino
Journal:  Case Rep Oncol       Date:  2015-02-03

9.  Primary Hepatic Lymphoma Mimicking a Hepatocellular Carcinoma in a Cirrhotic Patient: Case Report and Systematic Review of the Literature.

Authors:  Ali Bohlok; Thierry De Grez; Fikri Bouazza; Roland De Wind; Melody El-Khoury; Deborah Repullo; Vincent Donckier
Journal:  Case Rep Surg       Date:  2018-04-10

Review 10.  Histiocyte-rich reactive lymphoid hyperplasia of the liver: unusual morphologic features.

Authors:  Ho Sung Park; Kyu Yun Jang; Young Kon Kim; Baik Hwan Cho; Woo Sung Moon
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.